Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
20 June 2019
Vaccines Receives First Journal Impact Factor of 4.760
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Find support for a specific problem in the support section of our website.Get Support
Please let us know what you think of our products and services.Give Feedback
Visit our dedicated information section to learn more about MDPI.Get Information
The editors are pleased to inform that Vaccines has received a first Impact Factor of 4.760, as published in the 2018 Edition of the Journal Citation Reports®, released just now. Vaccines ranks 39th out of 158 (Q1) titles in the 'IMMUNOLOGY' category and 25th out of 136 (Q1) titles in 'MEDICINE, RESEARCH & EXPERIMENTAL'.
Thank you to the authors, editorial board members and reviewers for their contribution in achieving this milestone for Vaccines.